By Amanda Bronstad | December 16, 2019
The March 27 verdict, for plaintiff Edwin Hardeman, defied "regulatory judgment" and "sound science," Monsanto's lawyers wrote in their brief before the U.S. Court of Appeals for the Ninth Circuit.
By Amanda Bronstad | December 12, 2019
Kazan, McClain, Satterley & Greenwood retained Keker, Van Nest & Peters this week to defend against Johnson & Johnson's allegations that the plaintiffs firm provided false expert testimony in a trial over J&J's baby powder. The judge denied Johnson & Johnson's motion for mistrial, and closing arguments began Thursday.
By Amanda Bronstad | December 12, 2019
Kazan, McClain, Satterley & Greenwood retained Keker, Van Nest & Peters this week to defend against Johnson & Johnson's allegations that the plaintiffs firm provided false expert testimony in a trial over J&J's baby powder. The judge denied Johnson & Johnson's motion for mistrial, and closing arguments began Thursday.
New Jersey Law Journal | Analysis
By Vincent Lodato | December 12, 2019
With the increasing costs of mass tort litigation, and the expanding role of third-party litigation funders, familiarity with judicial decisions addressing the discoverability of litigation funding is particularly important.
By Amanda Bronstad | December 11, 2019
Impeachment wasn't the only topic before Congress this week: talc and Boeing also made the agenda.
By Amanda Bronstad | December 11, 2019
Johnson & Johnson, disputing the FDA's testing that found asbestos in a lot of its baby powder, said its CEO was not the appropriate person to testify at the hearing and that the committee's Democratic members rejected its alternatives.
By Amanda Bronstad | December 10, 2019
Johnson & Johnson, disputing the FDA's testing that found asbestos in a lot of its baby powder, said its CEO was not the appropriate person to testify at the hearing and that the committee's Democratic members rejected its alternatives.
By Amanda Bronstad | December 10, 2019
New venues to make the American Tort Reform Association's annual Top 10 list are Georgia, for its "nuclear verdicts," and Oklahoma, due to its $572 million judgment in the first trial over the opioid crisis.
By Amanda Bronstad | December 10, 2019
New venues to make the American Tort Reform Association's annual Top 10 list are Georgia, for its "nuclear verdicts," and Oklahoma, due to its $572 million judgment in the first trial over the opioid crisis.
By Amanda Bronstad | December 10, 2019
The Philadelphia Court of Common Pleas, where a jury awarded an $8 billion verdict against Johnson & Johnson, took the No. 1 spot. New venues to make the American Tort Reform Association's annual Top 10 list are Georgia, for its "nuclear verdicts," and Oklahoma, due to its $572 million judgment in the first trial over the opioid crisis.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law.com celebrates the California law firms and legal departments driving the state's dynamic legal landscape.
The Texas Lawyer honors attorneys and judges who have made a remarkable difference in the legal profession in Texas.
CORE RESPONSIBILITIES AND TASKS: Reporting to the Senior Vice President, Chief Legal Officer &...
Yale New Haven Health seeks a dynamic and collaborative executive to serve as its Vice President, Labor Strategy and Senior Associate Genera...
Nestled in the heart of Northern California Wine Country, Sonoma County is the largest county in the North Bay region of the San Francisco B...